In adults with suspected UC and ambiguous endoscopic findings, is MRE or capsule endoscopy preferred to clarify the diagnosis before biologic therapy

both tests are used to evaluate small-bowel lesions when standard endoscopy is atypical or unrevealing, and the retrieved evidence does not directly compare them or state which better clarifies the diagnosis before biologics in this scenario. capsule endoscopy is recommended in ulcerative colitis or IBD-unclassified patients who have been adequately evaluated with ileocolonoscopy and biopsies and who have atypical symptoms or medically refractory disease, if there are no contraindications ^1,2. a key caveat is that known or suspected stenosis contraindicates capsule endoscopy because of retention risk, and MRE (or a patency capsule) is used to assess for stenosis first ⁴. ^1–4

What is known: - Capsule endoscopy should be considered for patients with indeterminate colitis, those failing medical therapy or possibly needing colectomy, or with unexplained symptoms after standard endoscopy and radiography. ¹ - In ulcerative colitis or IBDU adequately evaluated with ileocolonoscopy and biopsies, capsule endoscopy is recommended when atypical symptoms or medically refractory disease are present, absent contraindications. ² - MRE is particularly useful for suspected intestinal stenosis and evaluating extraintestinal complications; capsule retention is a risk when stenosis is present, so patency must be confirmed. ⁴ - A diagnostic protocol for suspected Crohn's disease uses MRE or capsule patency testing when stenosis is known or suspected, since stenosis contraindicates the capsule. ⁴

What is unknown / caveats: - No head-to-head accuracy comparison of MRE vs capsule endoscopy in ambiguous UC in the retrieved excerpts - Excerpts do not address how either test changes the decision to start biologic therapy - Much of the comparative/protocol evidence is from Crohn's disease or pediatric populations - The excerpts describe indications and characteristics of each test but do not resolve which is superior for clarifying diagnosis before biologics in ambiguous ulcerative colitis.

## References

1. Legnani P, Abreu MT. Use of capsule endoscopy for established Crohn's disease. Gastrointest Endosc Clin N Am. 2006;16(2):299-306. PMID: 16644458.

2. Mehdizadeh S, Chen G, Enayati PJ, Cheng DW, Han NJ, Shaye OA, Ippoliti A, Vasiliauskas EA, Lo SK, Papadakis KA. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Endoscopy. 2008;40(1):30-5. PMID: 18058654.

3. Henderson P, Casey A, Lawrence SJ, Kennedy NA, Kingstone K, Rogers P, Gillett PM, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroenterol. 2012;107(6):941-9. PMID: 22370604.

4. Luján-Sanchis M, Sanchis-Artero L, Larrey-Ruiz L, Peño-Muñoz L, Núñez-Martínez P, Castillo-López G, González-González L, Clemente CB, Albert Antequera C, Durá-Ayet A, Sempere-Garcia-Argüelles J. Current role of capsule endoscopy in Crohn's disease. World J Gastrointest Endosc. 2016;8(17):572-83. PMID: 27668067.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

---

_Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._